Early study - faecal transplant to help slow early-stage motor neuron disease progression
A randomised clinical trial is looking at whether faecal microbiota transplantation (FMT) from healthy donors into adults with early-stage amyotrophic lateral sclerosis (ALS – one of the most common forms of motor neurone disease) can modulate the immune reaction during inflammation responses that characterise disease progression, and aims to investigate the relationship between specific gut bacteria and their action on immune system cells.
The preliminary findings by Dr Alessandra Guarnaccia from Columbus-Gemelli University Hospital IRCCS, Rome, Italy and ...









